Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVaxcyte Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$1.87 | -$1.67 | -$1.78 |
| Q2 2026 | 4 | -$2.20 | -$1.90 | -$2.06 |
| Q3 2026 | 4 | -$2.12 | -$2.12 | -$2.12 |
| Q4 2026 | 2 | -$2.11 | -$2.11 | -$2.11 |
| Q1 2027 | 2 | -$1.38 | -$1.38 | -$1.38 |
| Q2 2027 | 1 | -$1.43 | -$1.43 | -$1.43 |
| Q3 2027 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2027 | 2 | -$0.64 | -$0.64 | -$0.64 |
Vaxcyte Inc Earnings Date And Information
Vaxcyte Inc last posted its earnings results on Wednesday, May 6th, 2026. The company reported $-2.3 earnings per share for the quarter, missing analysts' consensus estimates of $-1.7775 by $0.5225. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Vaxcyte Inc has generated $-6 earnings per share over the last year ($-5.63 diluted earnings per share) and currently has a price-to-earnings ratio of -7.56. Vaxcyte Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Vaxcyte Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | -$1.78 | -$2.30 | -0.52 | $12.50 M | $0 |
| 02/24/2026 | Q4 2025 | -$1.53 | -$1.81 | -0.28 | $0 | $0 |
| 11/04/2025 | Q3 2025 | -$1.27 | -$1.56 | -0.29 | $0 | $0 |
| 08/06/2025 | Q2 2025 | -$1.12 | -$1.22 | -0.1 | N/A | $0 |
| 05/07/2025 | Q1 2025 | -$1.02 | -$1.04 | -0.02 | N/A | $0 |
| 02/25/2025 | Q4 2024 | -$1.16 | -$1.12 | 0.04 | N/A | $0 |
| 11/05/2024 | Q3 2024 | -$1.10 | -$0.83 | 0.27 | N/A | $0 |
| 08/06/2024 | Q2 2024 | -$0.98 | -$1.10 | -0.12 | N/A | $0 |
| 05/08/2024 | Q1 2024 | -$1.13 | -$0.85 | 0.28 | N/A | $0 |
| 02/27/2024 | Q4 2023 | -$0.90 | -$1.73 | -0.83 | N/A | $0 |
| 11/06/2023 | Q3 2023 | -$0.79 | -$0.91 | -0.12 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.67 | -$0.70 | -0.03 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$0.80 | -$0.70 | 0.1 | N/A | $0 |
| 02/27/2023 | Q4 2022 | -$0.84 | -$1.03 | -0.19 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$0.80 | -$0.93 | -0.13 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$0.69 | -$0.80 | -0.11 | N/A | $0 |
| 05/09/2022 | Q1 2022 | -$0.56 | -$0.68 | -0.12 | N/A | $0 |
| 02/28/2022 | Q4 2021 | -$0.46 | -$0.52 | -0.06 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$0.47 | -$0.51 | -0.04 | N/A | $0 |
| 08/11/2021 | Q2 2021 | -$0.46 | -$0.46 | 0 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vaxcyte Inc Earnings: FAQ's
The conference call for Vaxcyte Inc's latest earnings report can be listened to online.
The conference call transcript for Vaxcyte Inc's latest earnings report can be read online.
Vaxcyte Inc (:PCVX) has a recorded net income of $-766,628,000.Vaxcyte Inc has generated $-5.63 earnings per share over the last four quarters.
Vaxcyte Inc (:PCVX) has a price-to-earnings ratio of -7.56 and price/earnings-to-growth ratio is 0.16.